Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
75.4M
-
Shares change
-
-1.48M
-
Total reported value, excl. options
-
$537M
-
Value change
-
-$11.2M
-
Put/Call ratio
-
0.54
-
Number of buys
-
47
-
Number of sells
-
-70
-
Price
-
$7.12
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q1 2022
160 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q1 2022.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.4M shares
of 170M outstanding shares and own 44.23% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (14.4M shares), FMR LLC (13.9M shares), FEDERATED HERMES, INC. (8.01M shares), BlackRock Inc. (5.89M shares), JANUS HENDERSON GROUP PLC (5.81M shares), VANGUARD GROUP INC (5.07M shares), STATE STREET CORP (4.85M shares), GEODE CAPITAL MANAGEMENT, LLC (1.21M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (940K shares), and Ikarian Capital, LLC (841K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.